Sex differences in the pivotal MS clinical trials: what is the evidence?

被引：0
|
作者：
Bove, R. [1 ]
Houtchens, M. [2 ]
机构：
[1] Univ Calif San Francisco, Neurol, Sandler Neurosci Ctr, UCSF Neurol, San Francisco, CA 94143 USA
[2] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2018年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P926
引用
收藏
页码：503 / 503
页数：1
相关论文
共 50 条
  • [21] Sex differences in mineralocorticoid receptor antagonist trials: a pooled analysis of three large clinical trials
    Rossello, Xavier
    Ferreira, Joao Pedro
    Pocock, Stuart J.
    McMurray, John J. V.
    Solomon, Scott D.
    Lam, Carolyn S. P.
    Girerd, Nicolas
    Pitt, Bertram
    Rossignol, Patrick
    Zannad, Faiez
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (05) : 834 - 844
  • [22] It is time to conduct phase 3 clinical trials of sex hormones in MS - Yes
    Voskuhl, Rhonda
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (11) : 1413 - 1415
  • [23] Is it time to conduct phase 3 clinical trials of sex hormones in MS - Commentary
    Dubessy, Anne-Laure
    Stankoff, Bruno
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (11) : 1417 - 1418
  • [24] Strategies for increasing accrual in cancer clinical trials: What is the evidence?
    Michaels, Margo
    Weiss, Elisa S.
    Sae-Hau, Maria
    Illei, Dora
    Lilly, Bethany
    Szumita, Leah
    Connell, Brian
    Lee, Marialanna
    Cooks, Eric
    McPheeters, Melissa
    CANCER MEDICINE, 2024, 13 (10):
  • [25] Sex and Gender Differences in Kidney Cancer: Clinical and Experimental Evidence
    Peired, Anna Julie
    Campi, Riccardo
    Angelotti, Maria Lucia
    Antonelli, Giulia
    Conte, Carolina
    Lazzeri, Elena
    Becherucci, Francesca
    Calistri, Linda
    Serni, Sergio
    Romagnani, Paola
    CANCERS, 2021, 13 (18)
  • [26] Sex Differences in Severity and Progression of Interstitial Lung Disease in Systemic Sclerosis: What We Have Learned from Clinical Trials
    Volkmann, Elizabeth
    Li, Ning
    Roth, Michael
    Feghali-Bostwick, Carol
    Silver, Richard
    Frost, DeAnna Baker
    Assassi, Shervin
    Kim, Grace
    Goldin, Jonathan
    Tashkin, Donald
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [27] You get what you measure - Evaluating endpoints in MS clinical trials
    Marrie, Ruth Ann
    NEUROLOGY, 2008, 71 (09) : 620 - 621
  • [28] Representation of the population in need for pivotal clinical trials in lymphomas
    Casey, Mycal
    Odhiambo, Lorriane
    Aggarwal, Nidhi
    Shoukier, Mahran
    Islam, K. M.
    Cortes, Jorge
    BLOOD, 2023, 142 (09) : 846 - 855
  • [29] Efficacy results from pivotal clinical trials with abatacept
    Rozelle, A. L.
    Genovese, M. C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2007, 25 (05) : S30 - S34
  • [30] Efficacy of levetiracetam: A review of three pivotal clinical trials
    Privitera, M
    EPILEPSIA, 2001, 42 : 31 - 35
12345